Showing results (21-30 of 227) with videos related to
Sort By:
Pageof 23
American Journal of Hematology|June 17, 2026
Outcomes From the Multicenter ACCRU-LY-1804/CARiBOU TRIAL (Cytarabine, Acalabrutinib and Rituximab Integrated With Bortezomib-Based Outpatient Therapy) in 1st Line Mantle Cell LymphomaStephen D Smith, Suchitra Sundaram, Sharmila Giri, et al.Expert Opinion on Pharmacotherapy|September 15, 2015
Chemotherapy options for previously untreated acute myeloid leukemiaRyan C Lynch, Bruno C MedeirosBritish Journal of Haematology|May 3, 2024
Managing common toxicities associated with checkpoint inhibitor and chemotherapy combinations for untreated classic Hodgkin lymphomaThomas M Kuczmarski, Ryan C LynchSeminars in Radiation Oncology|December 13, 2024
Rising to the Top: How Immune-Checkpoint Inhibitors are Changing the Landscape of Treatment for Classic Hodgkin LymphomaRyan C Lynch, Michael Sargent BinkleyHematology. American Society of Hematology. Education Program|December 7, 2024
Has PD-1 blockade changed the standard of care for cHL?Thomas M Kuczmarski, Ryan C LynchAmerican Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 2, 2016
Risk-Adapted Treatment of Advanced Hodgkin Lymphoma With PET-CTRyan C Lynch, Ranjana H AdvaniCase Reports in Oncology|October 27, 2017
Dramatic Response with Single-Agent Ibrutinib in Multiply Relapsed Marginal Zone Lymphoma with MYD88<sup>L265P</sup> MutationRyan C Lynch, Ranjana H AdvaniClinical Lymphoma, Myeloma & Leukemia|November 24, 2025
Barriers to Investigator-Initiated Clinical Trial Enrollment in Frontline Large B-Cell LymphomaCarrie Ho, Neena Kennedy, Mengyang Di, et al.Blood|December 26, 2003
Fenretinide enhances rituximab-induced cytotoxicity against B-cell lymphoma xenografts through a caspase-dependent mechanismAjay K Gopal, John M Pagel, Nathan Hedin, et al.Current Opinion in Oncology|December 19, 2009
Recent advances in novel radioimmunotherapeutic approaches for allogeneic hematopoietic cell transplantationJaideep Shenoi, Ajay K Gopal, Oliver W Press, et al.Pageof 23